Cargando…
Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
BACKGROUND AND PURPOSE: Although plasmapheresis is becoming standard practice as a rescue therapy for neuromyelitis optica (NMO), evidence for the therapeutic efficacy of plasmapheresis is limited, and the effect of plasmapheresis on anti-aquaporin-4 (AQP4) levels in patients with NMO has not been r...
Autores principales: | Kim, Su-Hyun, Kim, Woojun, Huh, So-Young, Lee, Kyue Yim, Jung, In Ja, Kim, Ho Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543908/ https://www.ncbi.nlm.nih.gov/pubmed/23346159 http://dx.doi.org/10.3988/jcn.2013.9.1.36 |
Ejemplares similares
-
Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2012) -
Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies
por: Kim, Su-Hyun, et al.
Publicado: (2021) -
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020) -
Molecular Level Characterization of Circulating Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder
por: Li, Jie, et al.
Publicado: (2021) -
Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
por: Levy, Michael
Publicado: (2018)